90 T (Brilinta 90 mg)
Generic Name: ticagrelor
Pill with imprint 90 T is Yellow, Round and has been identified as Brilinta 90 mg. It is supplied by AstraZeneca.
Brilinta is used in the treatment of coronary artery disease; acute coronary syndrome; heart attack; cardiovascular risk reduction; ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. Risk cannot be ruled out during pregnancy. Brilinta 90 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 90 T
Brilinta
- Generic Name
- ticagrelor
- Imprint
- 90 T
- Strength
- 90 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Platelet aggregation inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00186-0777
- Inactive Ingredients
-
mannitol,
calcium phosphate dihydrate dibasic,
sodium starch glycolate type A potato,
hydroxypropyl cellulose,
magnesium stearate,
water,
hypromelloses,
titanium dioxide,
magnesium silicate,
polyethylene glycol 400,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "90 T"
More about Brilinta (ticagrelor)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (85)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: platelet aggregation inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.